: Our Impact

{Photo credit: MSH staff}Photo credit: MSH staff

COVID-19 is changing how malaria projects maintain programming in Nigeria. Before the pandemic, trainings and capacity-building efforts were conducted face-to-face, coupled with breakout sessions, where attendees huddled to discuss a topic or idea in-depth. But as public health experts recommend physical distancing to curb the spread of the coronavirus, face-to-face interactions are no longer considered a safe way to meet or share knowledge. To bridge this communications gap, organizations and programs worldwide are now utilizing virtual resources—an approach that has not been widely tested in training large groups of people in Nigeria, especially health care workers.

{Photo credit: MSH staff}Photo credit: MSH staff

COVID-19 is changing how malaria projects maintain programming in Nigeria. Before the pandemic, trainings and capacity-building efforts were conducted face-to-face, coupled with breakout sessions, where attendees huddled to discuss a topic or idea in-depth. But as public health experts recommend physical distancing to curb the spread of the coronavirus, face-to-face interactions are no longer considered a safe way to meet or share knowledge. To bridge this communications gap, organizations and programs worldwide are now utilizing virtual resources—an approach that has not been widely tested in training large groups of people in Nigeria, especially health care workers.

{Photo credit: MSH staff}Photo credit: MSH staff

COVID-19 is changing how malaria projects maintain programming in Nigeria. Before the pandemic, trainings and capacity-building efforts were conducted face-to-face, coupled with breakout sessions, where attendees huddled to discuss a topic or idea in-depth. But as public health experts recommend physical distancing to curb the spread of the coronavirus, face-to-face interactions are no longer considered a safe way to meet or share knowledge. To bridge this communications gap, organizations and programs worldwide are now utilizing virtual resources—an approach that has not been widely tested in training large groups of people in Nigeria, especially health care workers.

{Photo credit: MSH staff}Photo credit: MSH staff

COVID-19 is changing how malaria projects maintain programming in Nigeria. Before the pandemic, trainings and capacity-building efforts were conducted face-to-face, coupled with breakout sessions, where attendees huddled to discuss a topic or idea in-depth. But as public health experts recommend physical distancing to curb the spread of the coronavirus, face-to-face interactions are no longer considered a safe way to meet or share knowledge. To bridge this communications gap, organizations and programs worldwide are now utilizing virtual resources—an approach that has not been widely tested in training large groups of people in Nigeria, especially health care workers.

{Photo credit: MSH staff}Photo credit: MSH staff

COVID-19 is changing how malaria projects maintain programming in Nigeria. Before the pandemic, trainings and capacity-building efforts were conducted face-to-face, coupled with breakout sessions, where attendees huddled to discuss a topic or idea in-depth. But as public health experts recommend physical distancing to curb the spread of the coronavirus, face-to-face interactions are no longer considered a safe way to meet or share knowledge. To bridge this communications gap, organizations and programs worldwide are now utilizing virtual resources—an approach that has not been widely tested in training large groups of people in Nigeria, especially health care workers.

Arlington, VA—Management Sciences for Health (MSH) announced today that the US Agency for International Development (USAID) has awarded it two multiyear programs to eliminate tuberculosis (TB) in almost two dozen countries.“We are thrilled to accelerate and expand our locally led efforts to end TB around the globe,” said Marian W. Wentworth, MSH’s President and CEO. “These awards recognize MSH’s record of results fighting the world’s leading infectious disease killer.

Arlington, VA—Management Sciences for Health (MSH) announced today that the US Agency for International Development (USAID) has awarded it two multiyear programs to eliminate tuberculosis (TB) in almost two dozen countries.“We are thrilled to accelerate and expand our locally led efforts to end TB around the globe,” said Marian W. Wentworth, MSH’s President and CEO. “These awards recognize MSH’s record of results fighting the world’s leading infectious disease killer.

{Photo Credit Fabrice Duhal}Photo Credit Fabrice Duhal

Monitoring patients who are taking a new medicine is critical for patient safety and an essential component of a well-functioning pharmaceutical sector. The USAID MTaPS Program is working in Mozambique to establish an active surveillance system to assess the safety of an HIV drug in HIV/TB co-infected patients, including pregnant women, that has recently been introduced in the country. The concern for pregnant women stems from earlier indications of neural tube defect in babies born to women taking the medicine and the fact that women are disproportionately affected by HIV in Mozambique.

{Photo Credit Fabrice Duhal}Photo Credit Fabrice Duhal

Monitoring patients who are taking a new medicine is critical for patient safety and an essential component of a well-functioning pharmaceutical sector. The USAID MTaPS Program is working in Mozambique to establish an active surveillance system to assess the safety of an HIV drug in HIV/TB co-infected patients, including pregnant women, that has recently been introduced in the country. The concern for pregnant women stems from earlier indications of neural tube defect in babies born to women taking the medicine and the fact that women are disproportionately affected by HIV in Mozambique.

{Photo Credit Fabrice Duhal}Photo Credit Fabrice Duhal

Monitoring patients who are taking a new medicine is critical for patient safety and an essential component of a well-functioning pharmaceutical sector. The USAID MTaPS Program is working in Mozambique to establish an active surveillance system to assess the safety of an HIV drug in HIV/TB co-infected patients, including pregnant women, that has recently been introduced in the country. The concern for pregnant women stems from earlier indications of neural tube defect in babies born to women taking the medicine and the fact that women are disproportionately affected by HIV in Mozambique.

Pages